RaySearch Laboratories AB announces that the first patient in Australasia has been treated with a treatment plan created with RaySearch’s treatment planning system RayStation®. The treatment was carried out at Auckland Radiation Oncology in Auckland, New Zealand.
Auckland Radiation Oncology has established an international reputation for excellence in cancer treatment, offering the best in private healthcare. This leading radiation therapy treatment center in Auckland provides the highest standards of clinical skills with a team of experienced Radiation Oncologists, Radiation Therapists and Medical Physicists who are at the top of their profession. The first patient was treated for prostate cancer using Volumetric Modulated Arc Therapy (VMAT) and the treatment was delivered on an Elekta linear accelerator.
“For our clinic, RayStation® offers many advantages. The increased dose computational speed of the system gives us significant gains in managing our planning workload. Also, as we have treatment machines with different collimator types the use of RayStation’s fall-back planning functionality gives us more flexibility in transferring patients between the machines when required. Another highly important feature for us is dose tracking. That will allow us to fully utilize the information from the daily treatment verification imaging to account for changes in patient conditions such as weight changes to continually provide optimum treatment plans throughout the treatment regime to maximize tumor cell kill probability whilst sparing critical organs”, says Dr Bon Mzenda, Chief Physicist of Auckland Radiation Oncology.
“The team at Auckland Radiation Oncology is very competent and we are proud that we live up to their quality demands. RayStation® has been used clinically in North America and Europe for some time and now we reach the next important milestone when the system is used clinically in this region as well. We have several customers in Australia and New Zealand and see a growing interest for RayStation® in the region. We are now expanding our sales and service network and we look forward to helping Auckland Radiation Oncology and other clinics as they work hard every day to give cancer patients the best treatments possible”, says Johan Löf, CEO of RaySearch.
Dr. Mzenda concludes: “Overall we are very happy with RayStation® and RaySearch’s development team continues to do a good job in providing a planning system that promises to meet the ever-increasing challenges of modern advanced radiotherapy provision”.
About Auckland Radiation Oncology
Conveniently located in central Auckland, Auckland Radiation Oncology is a state of the art private radiation therapy facility that offers patients a first class journey towards wellness.
Patients receive timely, best possible care at a treatment centre that offers bench marked radiation treatment aimed directly at improving cancer treatment outcomes. Auckland Radiation Oncology is an inspired partnership between MercyAscot and Southern Cross Hospitals.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian, Accuray and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,000 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30